Tardive dyskinesia (TD) poses a substantial burden for both caregivers and patients, according to a study published online Nov. 28 in the Journal of Patient-Reported Outcomes.
Dec 8, 2023
0
16
The Biden administration is flexing some federal muscle in its push for lower drug prices, warning pharmaceutical companies that it might use its authority to cancel patent protections if a medication costs too much.
Dec 7, 2023
0
10
Isotretinoin users do not have an increased risk for suicide or psychiatric disorders and may have a lower risk for suicide attempts, according to a review published online Nov. 29 in JAMA Dermatology.
Dec 5, 2023
0
0
Development of potential or improved anti-cancer treatments is being blocked or slowed down by a lack of transparency in data sharing between pharmaceutical companies and research groups, according to cancer clinicians, researchers ...
Nov 21, 2023
0
0
The addition of pembrolizumab to standard platinum-pemetrexed chemotherapy results in significant improvement in overall survival among patients with advanced pleural mesothelioma, according to a study published online Nov. ...
Nov 15, 2023
0
0
Imagine a world where simple infections could become life-threatening, where a small cut could spell disaster, and where doctors couldn't treat diseases effectively anymore. This isn't the plot of a science fiction movie—it's ...
Nov 14, 2023
0
0
Inflammatory bowel diseases (IBDs), such as Crohn's disease or ulcerative colitis, arise when there is a dysregulation of the cell signaling pathways controlling the maintenance of homeostasis in the gut, leading to a chronic ...
Oct 26, 2023
0
0
The recent award of the 2023 Nobel prize in physiology or medicine to Katalin Karikó and Drew Weissman highlights the growing importance of RNA technology in the medical world, with many potential applications beyond COVID ...
Oct 26, 2023
0
0
For patients with chemorefractory metastatic colorectal cancer, the KRAS G12C inhibitor sotorasib in combination with the epidermal growth factor receptor inhibitor panitumumab results in longer progression-free survival ...
Oct 24, 2023
0
0
A case study on ketamine reveals systemic barriers that prevent repurposing existing low-cost drugs like ketamine for treatment-resistant depression.
Oct 23, 2023
0
0
